Examining the therapeutic potential of targeting the MDMX oncogene for the treatment of childhood sarcomas
The University of Adelaide
Channel 7 Children's Research Foundation
Miss Kathleen PISHAS
Sarcomas represent a group of bone or soft tissue cancers that disproportionally affect the young. Despite the implementation of intensive multi-modal treatment strategies, current five year survival rates for young South Australians diagnosed with bone cancer is only 56%, amongst the worst for all childhood cancers. Alternative systemic therapeutic options are urgently required to improve patient outcomes. Our research team is the only group within South Australia investigating the therapeutic potential of novel agents for the targeted treatment of these aggressive childhood cancers.